213 related articles for article (PubMed ID: 31130720)
1. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.
Bukauskas T; Mickus R; Cereskevicius D; Macas A
Med Sci Monit; 2019 May; 25():3925-3932. PubMed ID: 31130720
[TBL] [Abstract][Full Text] [Related]
2. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
3. miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction-Added Value over Left Ventricular Myocardial Work Indices.
Scărlătescu AI; Barbălată T; Sima AV; Stancu C; Niculescu LȘ; Micheu MM
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010296
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome.
Tong KL; Mahmood Zuhdi AS; Wan Ahmad WA; Vanhoutte PM; de Magalhaes JP; Mustafa MR; Wong PF
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762500
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs in patients with ST-elevation myocardial infarction.
Eryılmaz U; Akgüllü Ç; Beşer N; Yıldız Ö; Kurt Ömürlü İ; Bozdoğan B
Anatol J Cardiol; 2016 Jun; 16(6):392-6. PubMed ID: 27282672
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
Chen X; Huang F; Liu Y; Liu S; Tan G
Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction.
Cortez-Dias N; Costa MC; Carrilho-Ferreira P; Silva D; Jorge C; Calisto C; Pessoa T; Robalo Martins S; de Sousa JC; da Silva PC; Fiúza M; Diogo AN; Pinto FJ; Enguita FJ
Circ J; 2016 Sep; 80(10):2183-91. PubMed ID: 27593229
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction.
Coskunpinar E; Cakmak HA; Kalkan AK; Tiryakioglu NO; Erturk M; Ongen Z
Gene; 2016 Oct; 591(1):90-96. PubMed ID: 27374153
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-23b as a Novel Biomarker for Early Risk Stratification After ST-Elevation Myocardial Infarction.
Zhang J; Li Y; Zhao Q
Med Sci Monit; 2018 Mar; 24():1517-1523. PubMed ID: 29535290
[TBL] [Abstract][Full Text] [Related]
11. Discriminatory power of a circulating multi-noncoding RNA panel in acute coronary syndrome subtypes: Towards precision detection.
Agwa SHA; Elzahwy SS; Hossam N; Yahia YA; Hamady S; Sherif N; Elshazly A; Darwish RM; Hashim JO; Adly MA; Abd Elsamee AM; Shamekh R; Roushdy MMS; Matboli M
Int J Biochem Cell Biol; 2024 Apr; 169():106531. PubMed ID: 38280541
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.
Robinson S; Follo M; Haenel D; Mauler M; Stallmann D; Tewari M; Duerschmied D; Peter K; Bode C; Ahrens I; Hortmann M
Int J Cardiol; 2018 Apr; 257():247-254. PubMed ID: 29506703
[TBL] [Abstract][Full Text] [Related]
13. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
[TBL] [Abstract][Full Text] [Related]
14. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
[TBL] [Abstract][Full Text] [Related]
15. Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction.
Hsu A; Chen SJ; Chang YS; Chen HC; Chu PH
Biomed Res Int; 2014; 2014():418628. PubMed ID: 24900964
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction.
Xiao S; Xue T; Pan Q; Hu Y; Wu Q; Liu Q; Wang X; Liu A; Liu J; Zhu H; Zhou Y; Pan D
Cardiovasc Ther; 2021; 2021():2923441. PubMed ID: 34786024
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
Coelho-Lima J; Mohammed A; Cormack S; Jones S; Das R; Egred M; Panahi P; Ali S; Spyridopoulos I
Thromb Haemost; 2018 Jul; 118(7):1257-1269. PubMed ID: 29890520
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial Infarction.
Barbalata T; Scarlatescu AI; Sanda GM; Toma L; Stancu CS; Dorobantu M; Micheu MM; Sima AV; Niculescu LS
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077347
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction.
Xue S; Zhu W; Liu D; Su Z; Zhang L; Chang Q; Li P
Mol Med; 2019 May; 25(1):18. PubMed ID: 31092195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
